{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:13:54Z","timestamp":1774271634043,"version":"3.50.1"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,26]],"date-time":"2013-06-26T00:00:00Z","timestamp":1372204800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0067123","type":"journal-article","created":{"date-parts":[[2013,6,26]],"date-time":"2013-06-26T23:16:59Z","timestamp":1372288619000},"page":"e67123","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses"],"prefix":"10.1371","volume":"8","author":[{"given":"Tessa M.","family":"Lawrence","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celestine N.","family":"Wanjalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily A.","family":"Gomme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wirblich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Gatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Carnero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas S.","family":"Lyles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"McGettigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias J.","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,6,26]]},"reference":[{"key":"ref1","unstructured":"(2012) Estimated HIV incidence in the United States, 2007\u20132010. In: CDC, editor. HIV Surveillance Supplemental Report."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nm0703-839","article-title":"HIV and AIDS: 20 years of science","volume":"9","author":"AS Fauci","year":"2003","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199906033402203","article-title":"Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort","volume":"340","author":"JC Learmont","year":"1999","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/5557","article-title":"Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques","volume":"5","author":"TW Baba","year":"1999","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/clinids\/4.5.916","article-title":"A successful eradication campaign. Global eradication of smallpox","volume":"4","author":"F Fenner","year":"1982","journal-title":"Reviews of infectious diseases"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1016\/j.vaccine.2011.06.085","article-title":"Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review","volume":"29","author":"MP Girard","year":"2011","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1128\/JVI.64.8.3694-3700.1990","article-title":"Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV","volume":"64","author":"ML Marthas","year":"1990","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1586\/14760584.6.2.255","article-title":"Use of viral vectors for the development of vaccines","volume":"6","author":"M Liniger","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.1154258","article-title":"AIDS\/HIV. A STEP into darkness or light?","volume":"320","author":"JP Moore","year":"2008","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI60202","article-title":"Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine","volume":"122","author":"N Frahm","year":"2012","journal-title":"J Clin Invest"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"MJ Schnell","year":"1994","journal-title":"EMBO J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","article-title":"Recombinant vesicular stomatitis viruses from DNA","volume":"92","author":"ND Lawson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"11868","DOI":"10.1128\/JVI.75.23.11868-11873.2001","article-title":"Recombinant Newcastle disease virus as a vaccine vector","volume":"75","author":"T Nakaya","year":"2001","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1073\/pnas.93.14.7310","article-title":"Highly stable expression of a foreign gene from rabies virus vectors","volume":"93","author":"T Mebatsion","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1128\/JVI.77.20.10889-10899.2003","article-title":"Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome","volume":"77","author":"JP McGettigan","year":"2003","journal-title":"Journal of Virology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.virol.2005.09.004","article-title":"Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2","volume":"344","author":"JP McGettigan","year":"2006","journal-title":"Virology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/JVI.01515-07","article-title":"Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice","volume":"82","author":"D Cooper","year":"2008","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/JVI.01443-08","article-title":"Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses","volume":"83","author":"E Carnero","year":"2009","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1128\/JVI.05050-11","article-title":"Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs","volume":"85","author":"SK Khattar","year":"2011","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1128\/JVI.75.9.4430-4434.2001","article-title":"Response against Envelope Proteins from Cross-Reactive Cytotoxic T-Lymphocyte (HIV-1) Envelope Protein Induce a Strong, Human Immunodeficiency Virus Type 1 Rabies Virus-Based Vectors Expressing Different HIV-1 Isolates","volume":"75","author":"JP McGettigan","year":"2001","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/viro.2001.1212","article-title":"Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines","volume":"292","author":"CA Siler","year":"2002","journal-title":"Virology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1099\/vir.0.80844-0","article-title":"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies","volume":"86","author":"M Faber","year":"2005","journal-title":"J Gen Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.virol.2004.10.018","article-title":"Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach","volume":"331","author":"GS Tan","year":"2005","journal-title":"Virology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1086\/512243","article-title":"Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease","volume":"195","author":"PM McKenna","year":"2007","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.virol.2008.09.019","article-title":"Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity","volume":"382","author":"EJ Faul","year":"2008","journal-title":"Virology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.vaccine.2009.10.051","article-title":"Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge","volume":"28","author":"EJ Faul","year":"2009","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1128\/JVI.01870-09","article-title":"Characterization of a single-cycle rabies virus-based vaccine vector","volume":"84","author":"EA Gomme","year":"2010","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1128\/JVI.75.9.4430-4434.2001","article-title":"Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates","volume":"75","author":"JP McGettigan","year":"2001","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/JVI.77.8.4646-4657.2003","article-title":"Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis","volume":"77","author":"M Ahmed","year":"2003","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.1128\/JVI.00915-08","article-title":"Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus","volume":"82","author":"M Ahmed","year":"2008","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1128\/JVI.01572-09","article-title":"Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens","volume":"84","author":"CL Braxton","year":"2010","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Gerlier D, Lyles DS (2011) Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol Mol Biol Rev 75: 468\u2013490, second page of table of contents.","DOI":"10.1128\/MMBR.00007-11"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1128\/JVI.80.5.2194-2205.2006","article-title":"Matrix protein mutant of vesicular stomatitis virus stimulates maturation of myeloid dendritic cells","volume":"80","author":"M Ahmed","year":"2006","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1128\/JVI.02030-08","article-title":"Vesicular stomatitis virus M protein mutant stimulates maturation of Toll-like receptor 7 (TLR7)-positive dendritic cells through TLR-dependent and -independent mechanisms","volume":"83","author":"M Ahmed","year":"2009","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1128\/JVI.77.17.9522-9532.2003","article-title":"Newcastle disease virus V protein is a determinant of host range restriction","volume":"77","author":"MS Park","year":"2003","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1128\/JVI.00536-09","article-title":"A Y526Q mutation in the Newcastle disease virus HN protein reduces its functional activities and attenuates virus replication and pathogenicity","volume":"83","author":"SK Khattar","year":"2009","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1099\/vir.0.033399-0","article-title":"A single amino acid change, Q114R, in the cleavage-site sequence of Newcastle disease virus fusion protein attenuates viral replication and pathogenicity","volume":"92","author":"S Samal","year":"2011","journal-title":"J Gen Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.vaccine.2012.03.027","article-title":"Efficacy of three candidate Rift Valley fever vaccines in sheep","volume":"30","author":"J Kortekaas","year":"2012","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1016\/j.vaccine.2010.02.051","article-title":"Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1","volume":"28","author":"SK Khattar","year":"2010","journal-title":"Vaccine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/JVI.01946-09","article-title":"Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys","volume":"84","author":"JM DiNapoli","year":"2010","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"14680","DOI":"10.1073\/pnas.011510698","article-title":"A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection","volume":"97","author":"HD Foley","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/1570162033485320","article-title":"Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases","volume":"1","author":"PM McKenna","year":"2003","journal-title":"Curr HIV Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1128\/JVI.75.24.12169-12181.2001","article-title":"Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus","volume":"75","author":"SA Kopecky","year":"2001","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.vaccine.2010.08.042","article-title":"Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity","volume":"29","author":"CN Wanjalla","year":"2010","journal-title":"Vaccine"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection","volume":"68","author":"P Borrow","year":"1994","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques","volume":"189","author":"X Jin","year":"1999","journal-title":"J Exp Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"SP Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"MJ McElrath","year":"2008","journal-title":"Lancet"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/v1030832","article-title":"Interferon response and viral evasion by members of the family rhabdoviridae","volume":"1","author":"EJ Faul","year":"2009","journal-title":"Viruses"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1128\/JVI.74.13.5997-6005.2000","article-title":"Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway","volume":"74","author":"JT Qiu","year":"2000","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/JVI.74.6.2628-2635.2000","article-title":"Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene","volume":"74","author":"J zur Megede","year":"2000","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.77.1.237-244.2003","article-title":"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic","volume":"77","author":"JP McGettigan","year":"2003","journal-title":"J Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0067123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T05:25:35Z","timestamp":1596000335000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0067123"}},"subtitle":[],"editor":[{"given":"Elankumaran","family":"Subbiah","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,26]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0067123","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,26]]}}}